First report and characterization of a plasmid-encoded in a multi-drug resistant clinical isolate

Troy Skwor,Dan Jones,Caitlin Cahak,Ryan J Newton
DOI: https://doi.org/10.1101/2024.02.01.578490
2024-02-01
Abstract:Antibiotic resistance remains one of the most pressing public health issues facing the world today. At the forefront of this battle lies the ever-increasing identification of extended spectrum beta-lactamases and carbapenemases within human pathogens, conferring resistance towards broad-spectrum and last-resort anti-microbials. This study was prompted due to the identification of a pathogenic isolate (strain MAH-4) collected from abdominal fluid, which presented a robust resistance pattern against second, third, and fourth generation cephalosporins, ertapenem, ciprofloxacin, gentamicin, levofloxacin and moxifloxacin, and beta lactam/beta-lactamase inhibitor combinations. Whole genome sequencing was performed and identified a 328 kb plasmid (pMAH4) encoding 10 antibiotic resistance genes, including and of MAH-4. This is the first report of beta-lactamase SFO-1 within a clinical strain of . Due to the remarkable sequence identity of pMAH4 to plasmids associated with genera like , and the extensive capabilities of for horizontal gene transfer, our identification of a clinical isolate encoding SFO-1 on a plasmid suggests ARG mobility between and non- species.
Microbiology
What problem does this paper attempt to address?